Initial Experience of Atrial Septostomy Treatment for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: A Case Report
preprint
OA: closed
Abstract
Nonobstructive Hypertrophic Cardiomyopathy with preserved EF is a well-known ejection fraction preserved heart failure and oral medical therapy is the major treatment. Interatrial shunt devices have preliminarily been shown to be safe and efficacious for the treatment of HFpEF, their utilization in nonobstructive hypertrophic cardiomyopathy patients has not been describe
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-15T06:44:59.916582+00:00